BAYER DCA 2000+ BLOOD ANALYZER HEMOGLOBIN A1C

Bayer DCA 2000+ Hematology Analyzer

• Used, but like new!
• 90 day warranty!

The Bayer DCA 2000 + is a fully automated chemical analyzers. It is often the most workable choice to acquire results for hemoglobin A1c and microalbumin/creatinine tests in minutes. The manufacturer of this point-of-care diabetes management platform is Bayer Diagnostics (a division of Siemens).

This analyzer is useful to make immediate diabetes management adjustments, and thus protect the patients from the risks of retinopathy, neuropathy, and nephropathy. With this device, you can calculate low concentrations of albumin, creatinine and albumin/creatinine ratio in urine.

Bayer DCA 2000 +, better known for its accuracy and easy procedures, can produce the quantitative HbA1c value in 6 minutes. The features specific to DCA 2000 + are self-contained reagent cartridges (that means no reagent preparation, mixing, or handling), no costly, time-consuming calibration, sample collection capillary holder, screen displays (which provides full testing information, instructions, and calibration status), and adjust blood glucose control regimen.

• For achieving outstanding accuracy and precision, monoclonal antibody method is utilized. It has the ability to store 16 test results in memory for convenient retrieval of data.

• HbA1c and A:C Ratio testing results in just six and seven minutes, respectively.

• Increases patient comfort by requiring a smaller whole blood sample (1 uL) for HbA1c.

• Provides HbA1c patient trend graph.

• Online GFR calculator provides a tool for kidney disease staging.

Improved clinical confidence:

- Proven to provide accurate and precise lab-quality results.

- Barcode patient data entry to reduce transcription errors.

Enhanced productivity:

- Onboard printed results; eliminates transcription errors and saves time.

- Automatically uploads results to a LIS/HIS.

- Largest memory stores up to 4000 records; easily downloaded and transferred to a PC.

Proven simplicity:

- Add sample to test cartridge, load, and walk away.

- No sample or reagent preparation.

- Color touch screen display; easier menu navigation, data entry and recall.

- Minimal maintenance required with automatic reminders.

Easy procedure

• Totally self-contained reagent cartridges — no reagent preparation, mixing or handling
• Sample collection capillary holder is an integral part of unique reagent cartridge
• No costly, time-consuming calibration — factory-calibrated instrument eliminates all wet calibrations
• Screen displays all instructions, calibration status and testing information and results
• Up to 16 results stored in memory for convenient recordkeeping

Laboratory-accurate results just minutes after testing

• Review during patient visit, adjust blood glucose control regimen as appropriate
• Conforms with current guidelines for effective management

HbA1c results…in minutes

• Guide and reinforce your patients to maintain target blood glucose levels
• Quantitative HbA1c value in 6 minutes from capillary blood Low cost per test
• Monoclonal antibody method provides outstanding accuracy and precision
• Correlation study shows 99% agreement with the HPLC method
• Coefficients of variation <5% show excellent precision

Microalbumin/Creatinine ratio…in minutes

• In IDDM (insulin-dependent diabetes mellitus) patients, intensive insulin treatment:
• Delays the onset and slows the progression of microvascular complications
• Produces significant financial savings when part of long-term monitoring and control
• One reagent cartridge provides results for both microalbumin and creatinine as well as an automatic calculation of the albumin-to-creatinine ratio
• Quantitative results and calculated ratio displayed within 7 minutes using random urine sample.

Intensive management improves glycemic control

• Maintaining average blood glucose levels (120 mg/dL; 6.7 mmol/L; HbA1c 6%) lowers risk of complications.
• Three- to four-times-daily blood glucose monitoring is recommended.
• Establish and follow a coherent approach of combined nutritional counseling, self-management training and possible hospitalization for therapy initiation.

Reduce the risk. Monitor HbA1c levels

• HbA1c results monitor glucose control over the preceding 90 to 120 days.
• Complete normalization of glycemia levels may prevent complications.
• Quarterly HbA1c determination recommended for all insulin-treated patients.
• Recommendation also includes test for microalbuminuria and others, as indicated

Detect early stages of diabetic nephropathy. Protect your patient from complications

• Intensive diabetes management delays the onset of microalbuminuria -an early indicator of renal disease.
• Microalbumin-to-creatinine ratio from a random urine sample is as valid an indicator of microalbuminuria as a timed 24-hour sampling.
• Persistent microalbuminuria (30 to 300 mg/day) indicates the earliest stage of diabetic nephropathy.
• May also signal presence of hypertension and the need to begin antihypertensive therapy.
• Test for microalbuminuria should be performed yearly on postpubertal patients who have had diabetes for at least 5 years.